CSS LLC’s Harvard Bioscience HBIO Stock Holding History

CSS LLC’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-1,060	Closed	-$50K	–	688
2013 Q4	$50K	Buy	+1,060	New	+$46.3K	﹤0.01%	641

Other funds holding HBIO

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

F&C Asset Management Edinburgh, Scotland, United Kingdom $7.92B AUM 24.35% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CSS LLC's HBIO Position: Q1 2014 in Review

CSS LLC sold out of Harvard Bioscience (HBIO) in Q1 2014, closing a stake of 1,060 shares — an estimated $50K sold.

CSS LLC first reported a position in HBIO in Q4 2013 and held it in 1 quarter. The position peaked at $50K in Q4 2013. 74 funds tracked by Wall St. Rank hold HBIO as of Q1 2014.

CSS LLC reported no remaining Harvard Bioscience position as of Q1 2014 after selling out during the quarter.
CSS LLC sold 1,060 Harvard Bioscience shares in Q1 2014, an estimated $50K.
CSS LLC first reported a position in Harvard Bioscience in Q4 2013 and held it in 1 quarter.
CSS LLC's Harvard Bioscience position peaked at $50K in Q4 2013.
74 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2014.

Based on CSS LLC's 13F filing for Q1 2014, filed 15 May 2014.